Market Overview:
The global muscle spasm treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of neuromuscular disorders, rising geriatric population, and technological advancements in the field of muscle spasm treatment. The global muscle spasm treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into drug and service. The drug segment dominates the global muscle spasm treatment market owing to high adoption rates for drugs over services for treating muscle spasms. On the basis of application, hospitals account for a major share in terms of revenue contribution followed by clinics due to increasing demand for treatments related to neuromuscular disorders in these settings across regions worldwide.
Product Definition:
Muscle spasm treatment is the use of various therapies or medications to ease or stop muscle spasms. Muscle spasms are sudden, uncontrolled contractions of a muscle or group of muscles. They can cause pain and discomfort. There are many different types of muscle spasms, and the cause can vary from person to person.
Muscle spasm treatment is important because it can help relieve pain and discomfort caused by muscle spasms. It can also help prevent further injury to the affected muscles.
-Taking over-thecounter medications such as ibuprofen or acetaminophen to reduce inflammation.
Drug:
Drug, it's usage and growth factor in muscle spasm treatment market is expected to witness significant growth over the forecast period. The primary factor that propels the market growth is an increase in awareness about these drugs among physicians and patients. Moreover, a rise in healthcare spending by both public & private sectors coupled with technological advancements also contributes towards this market expansion.
Global drug, it's usage.
Service:
Service is a software application that helps in monitoring and analyzing muscle spasms. It also provides treatment options to the patient which are based on their response. The treatment options include Deep Vein Thrombosis (DVT) therapy, myofascial trigger point (MTP) massage, dry needling, soft tissue manipulation or myotherapy and other alternative therapies like acupuncture & reflexology.
Application Insights:
The clinics segment dominated the market for muscle spasm treatment and accounted for a revenue share of around 60.0% in 2017. The clinics offer cost-effective treatment options, which is likely to drive the segment growth over the forecast period. On the other hand, hospitals are estimated to be fastest growing application owing to their ability to provide highly specialized care and diagnosis at a higher rate than clinics.
Moreover, muscle spasms often recur after successful completion of drug therapy or surgery; this may lead doctors/surgeons/clinics to recommend continuous medication or surgical intervention in order for patients suffering from these conditions get relief as soon as possible. This is expected to further propel market growth during the forecast period due primarily on high unmet medical needs pertaining muscle spasms across various regions globally coupled with rising geriatric population base susceptible towards such disorders thereby driving demand globally over next few years (see figure below).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of key players, such as Johnson & Johnson Services, Inc.; Ortho-McNeil Pharmaceutical; and Merck Group. Moreover, rising prevalence of various orthopedic conditions coupled with high adoption rate for technologically advanced products is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to increasing geriatric population and growing disposable income levels in emerging economies such as China and India. In addition, favorable government initiatives pertaining towards healthcare expenditure are likely to contribute towards industry expansion over the next eight years.
Growth Factors:
- Increasing prevalence of muscle spasms and related disorders
- Growing awareness about the benefits of muscle spasm treatment
- Rising demand for minimally invasive treatments for muscle spasms
- Technological advancements in muscle spasm treatment methods
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Muscle Spasm Treatment Market Research Report
By Type
Drug, Service
By Application
Hospitals, Clinics
By Companies
Eisai Co., Ltd., Novartis International AG, GlaxoSmithKline plc, AstraZeneca plc, Pfizer, Inc., Roche
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Muscle Spasm Treatment Market Report Segments:
The global Muscle Spasm Treatment market is segmented on the basis of:
Types
Drug, Service
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eisai Co., Ltd.
- Novartis International AG
- GlaxoSmithKline plc
- AstraZeneca plc
- Pfizer, Inc.
- Roche
Highlights of The Muscle Spasm Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug
- Service
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Muscle Spasm Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Muscle spasm is a sudden, involuntary contraction of muscle fibers. Muscle spasms can be caused by a variety of factors, including injury, illness, or disease. Muscle spasms can cause pain and discomfort and may limit your ability to move or function effectively.nnThere are several different types of muscle spasm treatment options available to you. Some treatments involve medications that help relax the muscles and reduce the severity of the spasms. Other treatments involve physical therapy or other therapies that help improve your overall mobility and strength in the affected area.
Some of the major players in the muscle spasm treatment market are Eisai Co., Ltd., Novartis International AG, GlaxoSmithKline plc, AstraZeneca plc, Pfizer, Inc., Roche.
The muscle spasm treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Muscle Spasm Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Muscle Spasm Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Muscle Spasm Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Muscle Spasm Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Muscle Spasm Treatment Market Size & Forecast, 2018-2028
4.5.1 Muscle Spasm Treatment Market Size and Y-o-Y Growth
4.5.2 Muscle Spasm Treatment Market Absolute $ Opportunity
Chapter 5 Global Muscle Spasm Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Muscle Spasm Treatment Market Size Forecast by Type
5.2.1 Drug
5.2.2 Service
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Muscle Spasm Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Muscle Spasm Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Muscle Spasm Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Muscle Spasm Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Muscle Spasm Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Muscle Spasm Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Muscle Spasm Treatment Market Size Forecast by Type
9.6.1 Drug
9.6.2 Service
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Muscle Spasm Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Muscle Spasm Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Muscle Spasm Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Muscle Spasm Treatment Market Size Forecast by Type
10.6.1 Drug
10.6.2 Service
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Muscle Spasm Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Muscle Spasm Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Muscle Spasm Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Muscle Spasm Treatment Market Size Forecast by Type
11.6.1 Drug
11.6.2 Service
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Muscle Spasm Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Muscle Spasm Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Muscle Spasm Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Muscle Spasm Treatment Market Size Forecast by Type
12.6.1 Drug
12.6.2 Service
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Muscle Spasm Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Muscle Spasm Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Muscle Spasm Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Muscle Spasm Treatment Market Size Forecast by Type
13.6.1 Drug
13.6.2 Service
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Muscle Spasm Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Muscle Spasm Treatment Market: Competitive Dashboard
14.2 Global Muscle Spasm Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eisai Co., Ltd.
14.3.2 Novartis International AG
14.3.3 GlaxoSmithKline plc
14.3.4 AstraZeneca plc
14.3.5 Pfizer, Inc.
14.3.6 Roche
